Harmony Biosciences Holdings (HRMY) Other Non-Current Liabilities (2019 - 2026)

Harmony Biosciences Holdings has disclosed Other Non-Current Liabilities across 8 years of filings, most recently posting $5.3 million for Q1 2026.

• Other Non-Current Liabilities for Q1 2026 came in at $5.3 million, up 211.17% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.3 million (up 211.17% YoY), and the FY2025 annual result was $5.6 million, up 188.55% from the prior year.
• Other Non-Current Liabilities came in at $5.3 million for Q1 2026 at Harmony Biosciences Holdings, down from $5.6 million in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $5.6 million in Q4 2025 to a low of $1.2 million in Q3 2025.
• The 5-year median for Other Non-Current Liabilities is $1.9 million (2024), against an average of $2.5 million.
• Across the five-year window, Other Non-Current Liabilities surged 270.4% in 2022 and plunged 49.52% in 2023, its largest moves.
• Harmony Biosciences Holdings' Other Non-Current Liabilities stood at $2.5 million in 2022, then dropped by 15.57% to $2.1 million in 2023, then fell by 7.68% to $1.9 million in 2024, then surged by 188.55% to $5.6 million in 2025, then declined by 5.29% to $5.3 million in 2026.
• The last three Other Non-Current Liabilities figures came in at $5.3 million (Q1 2026), $5.6 million (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.